Figure-1: Distribution of gender (n=254).
Mean age group was 30-39 years (Figure-2) .
Figure-2: Distribution of age (n=254).
Regarding the USG findings of thyroid gland, 187 (74 %) had unilateral nodule and 67 (24 %) had bilateral nodules (Figure-3 ).
Figure-3: HRUS findings of thyroid nodules (n=254).
And, in relation to FNAC findings of thyroid nodules among this study sample (n=254), 223 (88%) had malignant cytology, 16 (6%) had borderline cytology and 15 (6%) had benign cytology ( Figure-4 ).
Figure-4: FNAC findings of thyroid nodules (n=254).
Regarding the histopathological findings of thyroid nodules, 241 (95 %) had papillary carcinoma and 13 (5 %) had follicular carcinoma (Figure-5).
Figure-5: Histopathology findings of thyroid nodules (n=254).
In relation to surgical management, 185 (73%) had undergone total thyroidectomy with central clearance, 48 (19%) had undergone total thyroidectomy with selective neck dissection, 13 (5%) had undergone completion thyroidectomy and 8 (3%) had undergone total thyroidectomy with modified radical neck dissection (Figure-6 ).
Figure-6: Types of undertaken neck surgery (n=254).
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Regarding radioiodine ablation dose, 198 (78%) had been given 138 millicurie (5.1 gigabecquerel) and 56 (22%) had been given 178 millicurie (6.6 gigabecquerel) And, in relation to treatment outcome from 2011 to 2016 among the sample (n=254), 26 (10%) were treated in 2011 and had recurred once (in 2014), 49 (20%) were treated in 2012 and had recurred twice (once in 2015 and once in 2016), 46 (18%) were treated in 2013 and had recurred twice in 2016, 49 (19%) were treated in 2014 and had recurred once in 2016 and 84 (33%) were treated in 2015 and had no recurrence upto 2016.
Discussion:
Thyroid cancer is the most common endocrine malignancy. The most frequent histologic subtype of thyroid carcinoma is papillary (accounting for 80.2% of cases), followed by follicular carcinoma (11.4% of cases), which are commonly collectively referred to as well-differentiated thyroid cancer 9 . In the systematic investigation of thyroid nodules, risk stratification is performed on the basis of the physical, ultrasonographic, and scintigraphic findings, and the diagnosis is generally established by fine-needle biopsy and cytology 10 . Papillary thyroid microcarcinoma (PTMC) is a specific subgroup of papillary thyroid carcinoma (PTC) and defined by WHO on the largest dimension of 1.0 cm or less. Most of PTMC are not detectable at clinical examination and are diagnosed incidentally during pathologic examination of thyroid specimens after surgery for benign thyroid diseases, or in autopsies. Characteristic cytologic features of PTC help make the diagnosis by FNA or after surgical resection; these include psammoma bodies, cleaved nuclei with an "orphan-Annie" appearance caused by large nucleoli, and the formation of papillary structures. Moreover, the increased accuracy of the pathologic thyroid examination, in particular with the thinness and the number of the anatomical slices obtained for thyroid specimens, led to a more frequent pathologic; diagnosis of incidental PTMC. On the other hand, the widespread use and the technical improvement of thyroid ultrasonography and fine-needle aspiration biopsy (FNAB) contributed to an increase in the rate of preoperative diagnosis of PTMC over the last few decades 11 .
Conclusion:
The incidence of thyroid cancer has increased dramatically during the past three decades and it is now the fastest growing cancer in women 12 .Therefore, early and successful management of differentiated thyroid carcinoma is required to practice widely and equitably in order to significantly reduce mortality and morbidity related to such conditions. Through the findings of this study, such well-established management protocol has been highlighted at this tertiary level at Rajshahi, Bangladesh. However, large-scale relevant studies are required to evaluate ongoing management protocol so that global standard can be achieved.
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